ArticleCurrent oncology (Toronto, Ont.)2024
Survival Outcomes for US and Canadian Patients Diagnosed with Hodgkin Lymphoma before and after Brentuximab Vedotin Approval for Relapsed/Refractory Disease: A Retrospective Cohort Study.
Gwynivere A Davies et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.